BioMarin to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 10 at 12:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced that its CEO, Jean-Jacques Bienaimé, and CFO, Brian Mueller, will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 10, 2020, at 12:30 PM ET. An audio webcast will be available live and can be accessed here. An archived version will also be accessible on the company's website afterward. BioMarin develops innovative therapies for serious rare disorders and has six commercialized products along with several candidates in the pipeline.

News Market Reaction – BMRN

+5.18%

+5.18% Session move

In the trading session that priced this news, BMRN gained 5.18%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Nov. 4, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, and Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 10, 2020 at 12:30pm ET.  An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-credit-suisse-29th-annual-virtual-healthcare-conference-on-november-10-at-1230pm-et-301166116.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin participate in the Credit Suisse virtual healthcare conference?

BioMarin will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 10, 2020, at 12:30 PM ET.

Who from BioMarin will speak at the Credit Suisse conference?

Jean-Jacques Bienaimé, Chairman and CEO, and Brian Mueller, CFO, will represent BioMarin at the conference.

How can I access the BioMarin conference webcast?

The live audio webcast can be accessed at BioMarin's investor relations website at https://investors.biomarin.com/.

What does BioMarin specialize in?

BioMarin specializes in developing therapies for serious and life-threatening rare disorders, with a portfolio of six commercial products.